mofezolac has been researched along with Fetal Resorption in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Fetal Resorption: The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption (see EMBRYO LOSS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mofezolac (N-22) is a new developed analgesic and anti-inflammatory agent." | 1.28 | [Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration]. ( Fuchigami, K; Kodama, R; Matsunaga, K; Otsuka, T; Sameshima, K; Yamakita, O, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchigami, K | 1 |
| Otsuka, T | 1 |
| Sameshima, K | 1 |
| Matsunaga, K | 1 |
| Kodama, R | 1 |
| Yamakita, O | 1 |
1 other study available for mofezolac and Fetal Resorption
| Article | Year |
|---|---|
[Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; | 1990 |